Octreotide in pediatric patients

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):600-9. doi: 10.1097/00005176-200211000-00003.
No abstract available

Publication types

  • Review

MeSH terms

  • Antidiarrheals* / adverse effects
  • Antidiarrheals* / pharmacology
  • Antidiarrheals* / therapeutic use
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Child
  • Diarrhea / drug therapy
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / pharmacology
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Diseases / drug therapy*
  • Gastrointestinal Hemorrhage / drug therapy
  • Gastrointestinal Motility / drug effects
  • Gastrointestinal Neoplasms / drug therapy
  • Humans
  • Octreotide* / adverse effects
  • Octreotide* / pharmacology
  • Octreotide* / therapeutic use
  • Pancreatitis / drug therapy
  • Treatment Outcome

Substances

  • Antidiarrheals
  • Antineoplastic Agents, Hormonal
  • Gastrointestinal Agents
  • Octreotide